Ayurveda and Yoga trial for preventing COVID 19 among healthcare workers

Evaluation of the prophylactic effect of Comprehensive Ayurveda and Mindfulness-based Yoga regimen among health care workers (HCW) of a tertiary care hospital in Delhi during COVID 19 Pandemic: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026151

Enrollment

452

Registered

2020-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: comprehensive Ayurveda and Mindfulness based Yoga module: The participants in the intervention group will receive comprehensive Ayurveda and yoga regimen/therapy which will be administe

Eligibility

Inclusion criteria

Inclusion criteria: a. Aged 18-60 years b. Both genders c. AIIMS employee from any department(OPD/IPD) with risk of exposure to COVID-19 cases d. No history of symptoms attributable to COVID-19 or any acute respiratory illness e. Willingness and ability to comply with trial and follow-up procedures. f. Ability to understand the nature of the trial and give written/e-consent informed consent

Exclusion criteria

Exclusion criteria: a. Suspected or confirmed current COVID-19, as determined by treating physician b. Pregnant or Nursing women c. Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol. d. Any other condition which the investigators feels, may interfere with the study outcomes

Design outcomes

Secondary

Measure	Time frame
a. Psychological distress among HCWs by using General Anxiety Disorder (GAD) and Patient Heath Questionnaire 9 (PHQ-9) b. Quality of Life among HWCs using short form 36 Questionnaire c. Routine Biochemical investigations such as CBC, Absolute Blood Count, Absolute neutrophil count, Absolute Lymphocyte count, LFT, KFT Timepoint: Baseline, and end of 12th Week	—

Primary

Measure	Time frame
Incidence of confirmed COVID-19 positive cases detection in experimental arm compared to controlTimepoint: Baseline, 8th week, 12th Week	—

Countries

India

Contacts

Public ContactDr Gautam Sharma

All India Institute of Medical Sciences, New Delhi

cimraiimsdelhi@gmail.com01126549325

Outcome results